You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-ErbB 3 antibody [RTJ2] (ab20161)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-ErbB 3 antibody [RTJ2]
See all ErbB 3 products (19) ...

Description

Mouse monoclonal [RTJ2] to ErbB 3

Tested applications

IHC-P, Flow Cyt, IP, WB, ELISA, ICC/IFmore details

Cross reactivity

Reacts with

Human

Immunogen

Synthetic peptide: ELEPELDLDLDLE (Human)

ELEPELDLDL DLE

Properties

Form

Liquid

Storage instructions

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: None
Constituents: PBS

Concentration

Concentration information loading...

Purity

IgG fraction

Clonality

Monoclonal

Clone number

RTJ2

Myeloma

NS0

Isotype

IgG1

Light chain type

unknown

  • Immunocytochemistry/ Immunofluorescence - ErbB 3 antibody [RTJ2] (ab20161)Immunocytochemistry/ Immunofluorescence - ErbB 3 antibody [RTJ2] (ab20161) image (enlarge)

  • Flow Cytometry - ErbB 3 antibody [RTJ2] (ab20161)Flow Cytometry - ErbB 3 antibody [RTJ2] (ab20161) image (enlarge)

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ErbB 3 antibody [RTJ2] (ab20161)Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ErbB 3 antibody [RTJ2] (ab20161) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab20161 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Binds and is activated by neuregulins and NTAK.

Tissue specificity

Epithelial tissues and brain.

Involvement in disease

Defects in ERBB3 are the cause of lethal congenital contracture syndrome type 2 (LCCS2) [MIM:607598]; also called Israeli Bedouin multiple contracture syndrome type A. LCCS2 is an autosomal recessive neurogenic form of a neonatally lethal arthrogryposis that is associated with atrophy of the anterior horn of the spinal cord. The LCCS2 syndrome is characterized by multiple joint contractures, anterior horn atrophy in the spinal cord, and a unique feature of a markedly distended urinary bladder. The phenotype suggests a spinal cord neuropathic etiology.

Sequence similarities

Belongs to the protein kinase superfamily. Tyr protein kinase family. EGF receptor subfamily.
Contains 1 protein kinase domain.

Developmental stage

Overexpressed in a subset of human mammary tumors.

Domain

The cytoplasmic part of the receptor may interact with the SH2 or SH3 domains of many signal-transducing proteins.

Post-translational
modifications

Ligand-binding increases phosphorylation on tyrosine residues and promotes its association with the p85 subunit of phosphatidylinositol 3-kinase.

Cellular localization

Secreted and Cell membrane.

Target information above from: UniProt accessionP21860 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • c erbB 3 antibody
  • c erbB3 antibody
  • ERBB3 antibody
  • ERBB3 protein antibody
  • erbB3 S antibody
  • ERBB3_HUMAN antibody
  • Glial growth factor receptor antibody
  • HER 3 antibody
  • HER3 antibody
  • LCCS2 antibody
  • MDA BF 1 antibody
  • MGC88033 antibody
  • p180 ErbB3 antibody
  • p45 sErbB3 antibody
  • p85 sErbB3 antibody
  • proto-oncogene-like protein c ErbB 3 antibody
  • proto-oncogene-like protein c ErbB3 antibody
  • Proto-oncogene-like protein c-ErbB-3 antibody
  • receptor tyrosine protein kinase ERB3 [precursor] antibody
  • Receptor tyrosine protein kinase erbB 3 antibody
  • Receptor tyrosine protein kinase erbB3 antibody
  • Receptor tyrosine-protein kinase erbB-3 antibody
  • Tyrosine kinase type cell surface receptor HER3 antibody
  • Tyrosine kinase-type cell surface receptor HER3 antibody
  • V erb b2 avian erythroblastic leukemia viral oncogene homolog 3 antibody
  • v erb b2 erythroblastic leukemia viral oncogene homolog 3 (avian) antibody
  • v erb b2 erythroblastic leukemia viral oncogene homolog 3 antibody
see all

Anti-ErbB 3 antibody [RTJ2] images:

  Immunocytochemistry/ Immunofluorescence - ErbB 3 antibody [RTJ2] (ab20161)

Immunocytochemistry/ Immunofluorescence - ErbB 3 antibody [RTJ2] (ab20161)

ICC/IF image of ab20161 stained HeLa cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal Goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab20161, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 Goat anti-Mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

  Flow Cytometry - ErbB 3 antibody [RTJ2] (ab20161)

Flow Cytometry - ErbB 3 antibody [RTJ2] (ab20161)

Overlay histogram showing HeLa cells stained with ab20161 (red line). The cells were fixed with methanol (5 min) and incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab20161, 1µg/1x106 cells) for 30 min at 22ºC. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H&L) (ab69879) at 1/250 dilution for 30 min at 22ºC. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HeLa cells fixed with 4% paraformaldehyde (10 min) used under the same conditions.

Please note that Abcam does not have data for use of this antibody on non-fixed cells. We welcome any customer feedback.

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ErbB 3 antibody [RTJ2] (ab20161)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ErbB 3 antibody [RTJ2] (ab20161)

IHC image of ab20161 staining in Human Hippocampus formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab20161, 5µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

References for Anti-ErbB 3 antibody [RTJ2] (ab20161)

This product has been referenced in:

  • Srinivasan Ret al. Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types. J Pathol 185:236-45 (1998).Read more (PubMed: 9771476) »

See 1 publication for this product

Publishing research using ab20161? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"